在MDS和AML中改善治疗的p53生物学和重新激活
1Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. Joanna.zawacka-pankau@ki.se.
Biomarker research
|March 14, 2024
概括
在骨髓质疏松症候群 (MDS) 和急性骨髓性白血病 (AML) 中的TP53突变导致不良结果. 恢复野生型或突变型p53的活性是有希望的,但需要进一步的临床研究来更好地评估风险.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 骨髓质疏松症候群 (MDS) 和急性骨髓性白血病 (AML) 是由于CHIP或CCUS等白血病前疾病引起的.
- 在MDS和AML的结果有很大的差异,即使是有针对性的疗法.
- TP53突变与骨髓瘤恶性瘤的最差预后有关.
研究的目的:
- 审查目前对MDS和AML中p53生物学的理解.
- 讨论针对野生类型和突变p53.3的治疗策略.
- 评估p53再激活疗法的临床试验结果.
主要方法:
- 对MDS和AML中TP53突变研究的文献综述.
- 对p53向治疗的临床试验数据的分析.
- 讨论p53功能障碍和重新激活的分子机制.
主要成果:
- 突变TP53的骨髓性恶性瘤表现出复杂的细胞遗传学和对标准治疗的反应不佳.
- 双性TP53突变与治疗影响下的一年以下的存活率有关.
- TP53等位基对结果的影响仍在调查中.
- 在ICC分类中,TP53突变的MDS,MDS/AML和AML现在是不同的实体.
结论:
- TP53突变代表了MDS和AML的关键负预后因素.
- 针对p53/MDM2/MDM4相互作用或突变p53重新折叠/降解是治疗途径.
- 需要进一步的研究来澄清TP53LOH状态在风险分层中的作用.
- 对p53再激活疗法的临床试验提供了希望,但结果不一.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K


